Literature DB >> 28209614

Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.

Yuli Wang1, Pengju Zhang2, Yunshan Wang1,3, Panpan Zhan2, Chunyan Liu2, Jian-Hua Mao4, Guangwei Wei5.   

Abstract

The ErbB3 receptor-binding protein EBP1 encodes two alternatively spliced isoforms P48 and P42. While there is evidence of differential roles for these isoforms in tumorigenesis, little is known about their underlying mechanisms. Here, we demonstrate that EBP1 isoforms interact with the SCF-type ubiquitin ligase FBXW7 in distinct ways to exert opposing roles in tumorigenesis. EBP1 P48 bound to the WD domain of FBXW7 as an oncogenic substrate of FBXW7. EBP1 P48 binding sequestered FBXW7α to the cytosol, modulating its role in protein degradation and attenuating its tumor suppressor function. In contrast, EBP1 P42 bound to both the F-box domain of FBXW7 as well as FBXW7 substrates. This adapter function of EBP1 P42 stabilized the interaction of FBXW7 with its substrates and promoted FBXW7-mediated degradation of oncogenic targets, enhancing its overall tumor-suppressing function. Overall, our results establish distinct physical and functional interactions between FBXW7 and EBP1 isoforms, which yield their mechanistically unique isoform-specific functions of EBP1 in cancer. Cancer Res; 77(8); 1983-96. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28209614      PMCID: PMC5392370          DOI: 10.1158/0008-5472.CAN-16-2246

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication.

Authors:  P Nash; X Tang; S Orlicky; Q Chen; F B Gertler; M D Mendenhall; F Sicheri; T Pawson; M Tyers
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

2.  Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48.

Authors:  Hyo Rim Ko; Chung Kwon Kim; Jee-Yin Ahn
Journal:  Mol Carcinog       Date:  2014-08-23       Impact factor: 4.784

3.  Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.

Authors:  Jonathan E Grim
Journal:  Gut       Date:  2013-09-02       Impact factor: 23.059

4.  The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

Authors:  Dong Zhao; Han-Qiu Zheng; Zhongmei Zhou; Ceshi Chen
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 5.  FBW7-mediated ubiquitination and degradation of KLF5.

Authors:  Yi Luan; Ping Wang
Journal:  World J Biol Chem       Date:  2014-05-26

6.  The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.

Authors:  Alena Malyukova; Takeaki Dohda; Natalie von der Lehr; Shahab Akhoondi; Shahab Akhondi; Martin Corcoran; Mats Heyman; Charles Spruck; Dan Grandér; Urban Lendahl; Olle Sangfelt
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

7.  The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Authors:  Baoying Hu; Yicheng Xiong; Runzhou Ni; Lixian Wei; Dawei Jiang; Gang Wang; Di Wu; Tianxin Xu; Fengbo Zhao; Mingyan Zhu; Chunhua Wan
Journal:  Mol Cell Biochem       Date:  2014-08-01       Impact factor: 3.396

8.  Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.

Authors:  Le Xuan Truong Nguyen; Li Zhu; Yunqin Lee; Lynn Ta; Beverly S Mitchell
Journal:  Clin Cancer Res       Date:  2016-01-26       Impact factor: 12.531

9.  CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.

Authors:  Yunshan Wang; Mingxin Wen; Yongwon Kwon; Yangyang Xu; Yueyong Liu; Pengju Zhang; Xiuquan He; Qin Wang; Yurong Huang; Kuang-Yu Jen; Mark A LaBarge; Liang You; Scott C Kogan; Joe W Gray; Jian-Hua Mao; Guangwei Wei
Journal:  Cancer Res       Date:  2013-12-04       Impact factor: 12.701

10.  Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.

Authors:  Hayley Davis; Annabelle Lewis; Axel Behrens; Ian Tomlinson
Journal:  Gut       Date:  2013-05-15       Impact factor: 31.793

View more
  12 in total

1.  ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells.

Authors:  Eun Hee Han; Puja Singh; In-Kyu Lee; Raul Urrutia; Young-In Chi
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

2.  Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice.

Authors:  Inwoo Hwang; Byeong-Seong Kim; Hyo Rim Ko; Seongbong Cho; Ho Yun Lee; Sung-Woo Cho; Dongryeol Ryu; Sungbo Shim; Jee-Yin Ahn
Journal:  Mol Psychiatry       Date:  2022-02-15       Impact factor: 13.437

Review 3.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

4.  Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression.

Authors:  Wang Wei; Zhang Xiao Jing; Zheng Ke; Pei Yi
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

5.  Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.

Authors:  Jennifer Y Wang; Bing Zhu; LaNisha L Patterson; Madison R Rogan; Clayton E Kibler; Jere W McBride
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

6.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.

Authors:  Yeong Jun Kim; Yuri Kim; Abhishek Kumar; Chan Woo Kim; Zsolt Toth; Nam Hyuk Cho; Hye-Ra Lee
Journal:  PLoS Pathog       Date:  2021-01-20       Impact factor: 6.823

Review 7.  The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease.

Authors:  Inwoo Hwang; Hyo Rim Ko; Jee-Yin Ahn
Journal:  Exp Mol Med       Date:  2020-07-27       Impact factor: 8.718

8.  Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis.

Authors:  Wei Shang; Chuanwang Yan; Ran Liu; Lili Chen; Dongdong Cheng; Liang Hao; Wenguang Yuan; Jingbo Chen; Hui Yang
Journal:  BMC Cancer       Date:  2021-07-03       Impact factor: 4.430

Review 9.  FBXW7: a critical tumor suppressor of human cancers.

Authors:  Chien-Hung Yeh; Marcia Bellon; Christophe Nicot
Journal:  Mol Cancer       Date:  2018-08-07       Impact factor: 27.401

10.  miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Yuli Wang; Shuang Shi; Yunshan Wang; Xuhua Zhang; Xiaoyan Liu; Juan Li; Peilong Li; Lutao Du; Chuanxin Wang
Journal:  Thorac Cancer       Date:  2021-12-24       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.